Depression and Alzheimer's disease: Novel postmortem brain studies reveal a possible common mechanism

Journal of Alzheimer's Disease

Volumn 37, Issue 3, 2013, Pages 611-621

  Nihonmatsu Kikuchi, Naomi ^a   Hayashi, Yoshitaka ^a,b   Yu, Xiu Jun ^a,c   Tatebayashi, Yoshitaka ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; fatty acids; flow cytometry; major depressive disorder; myelin; myelination; oligodendroglia; postmortem brain

Indexed keywords

FATTY ACID; MYELIN;

ALZHEIMER DISEASE; BRAIN REGION; CELL COUNTING; DEATH; DISEASE ASSOCIATION; FRONTOPOLAR CORTEX; GRAY MATTER; HIPPOCAMPUS; HUMAN; LIPID COMPOSITION; MAJOR DEPRESSION; MYELINATION; OLIGODENDROGLIA; PATHOLOGICAL ANATOMY; POSTMORTEM BRAIN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DEPRESSION; DIAGNOSIS; FATTY ACIDS; HUMANS; MYELIN SHEATH; OLIGODENDROGLIA;

EID: 84892770541     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130752     Document Type: Review

References (53)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62, 593-602.
2. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Cara-bin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gos-selin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Har-ing D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lal-loo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilim-baris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weis-skopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, AlMazroa MA, Memish ZA (2010) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197-2223.
3. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006) Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63, 530-538.
4. Byers AL, Yaffe K (2011) Depression and risk of developing dementia. Nat Rev Neurol 20, 664-672.
5. Hayashi Y, Nihonmatsu-Kikuchi N, Hisanaga SI, Tatebayashi Y (2011a) A novel, rapid, cell-counting method for unfixed frozen brains comprehensively quantifies at least four neural cell populations. Mol Psychiatry 16, 1155.
6. Hayashi Y, Nihonmatsu-Kikuchi N, Yu X, Ishimoto K, Hisanaga SI, Tatebayashi Y (2011) A novel, rapid, quantitative cell-counting method reveals oligodendroglial reduction in the frontopolar cortex in major depressive disorder. Mol Psychiatry 16, 1156-1158.
7. Hayashi Y, Nihonmatsu-Kikuchi N, Hisanaga SI, Yu X, Tatebayashi Y (2012) Neuropathological similarities and differences between schizophrenia and bipolar disorder: A flow cytometric postmortem brain study. PLoS ONE 7, e33019.
8. Tatebayashi Y, Nihonmatsu-Kikuchi N, Hayashi Y, Yu X, Soma M, Ikeda K (2012) Abnormal fatty acid composition in the frontopolar cortex of patients with affective disorders. Transl Psychiatry 2, e204.
9. Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 9, 197-201.
10. Benes FM, Turtle M, Khan Y, Farol P (1994) Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 51, 477-484.
11. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO (1994) A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 51, 874-887.
12. Kral VA, Emery OB (1989) Long-term follow-up of depressive pseudodementia of the aged. Can J Psychiatry 34, 445-446.
13. Jorm AF (2001) History of depression as a risk factor for dementia: An updated review. Aust N Z J Psychiatry 35, 776-781.
14. Geerlings MI, den Heijer T, Koudstaal PJ, Hofman A, Breteler MM (2008) History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology 70, 1258-1264.
15. Dotson VM, Beydoun MA, Zonderman AB (2010) Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75, 27-34.
16. Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA (2012) Midlife vs late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer disease and vasculardementia. Arch Gen Psychiatry69, 493-498.
17. Irie F, Masaki KH, Petrovitch H, Abbott RD, Ross GW, Taaffe DR, Launer LJ, White LR (2008) Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: The Honolulu-Asia Aging Study. Arch Gen Psychiatry 65, 906-912.
18. Krishnan KR, Tupler LA, Ritchie JC Jr, McDonald WM, Knight DL, Nemeroff CB, Carroll BJ (1996) Apolipoprotein E-ε4 frequency in geriatric depression. Biol Psychiatry 40, 69-71.
19. Rigaud AS, Traykov L, Caputo L, Coste J, Latour F, Couderc R, Moulin F, Boller F, Forette F (2001) Association of the apolipoprotein E ε4 allele with late-onset depression. Neu-roepidemiology 20, 268-272.
20. Scarmeas N, Brandt J, Albert M, Devanand DP, Marder K, Bell K, Ciappa A, Tycko B, Stern Y (2002) Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology 58, 1182-1188.
21. Craig D, Hart DJ, McIlroy SP, Passmore AP (2005) Association analysis of apolipoprotein E genotype and risk of depressive symptomsin Alzheimer's disease. Dement Geriatr Cogn Disord 19, 154-157.
22. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827.
23. Drevets WC (2007) Orbitofrontal cortex function and structure in depression. Ann N Y Acad Sci 1121, 499-527.
24. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K (2002) Depression: Perspectives from affective neuroscience. Annu Rev Psychol 53, 545-574.
25. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR (1984) Mood disorders in stroke patients. Importance of location of lesion. Brain 107, 81-93.
26. Singh A, Herrmann N, Black SE (1998) The importance of lesion location in poststroke depression: A critical review. Can J Psychiatry 43, 921-927.
27. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, Sharpe M (2000) Depression after stroke and lesion location: A systematic review. Lancet 356, 122-126.
28. Koenigs M, Huey ED, Calamia M, Raymont V, Tranel D, Grafman J (2008) Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J Neurosci 28, 12341-12348.
29. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminow-icz D, Hamani C, Schwalb JM, Kennedy SH (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45, 651-660.
30. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchin-ski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nat Neurosci8, 828-834.
31. Holtzheimer PE, Kelley ME, Gross RE, Filkowski MM, Gar-low SJ, Barrocas A, Wint D, Craighead MC, Kozarsky J, Chismar R, Moreines JL, Mewes K, Posse PR, Gutman DA, Mayberg HS (2012) Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 69, 150-158.
32. Ongür D, Drevets WC, Price JL (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95, 13290-13295.
33. Cotter D, Mackay D, Landau S, Kerwin R, Everall I (2001) Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58, 545-553.
34. Nishiyama A, Komitova M, Suzuki R, Zhu X (2009) Poly-dendrocytes (NG2 cells): Multifunctional cells with lineage plasticity. Nat Rev Neurosci 10, 9-22.
35. Herculano-Houzel S, Lent R (2005) Isotropic fractionator: A simple, rapid method for the quantification of total cell and neuron numbers in the brain. J Neurosci 25, 2518-2521.
36. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH (2000) The Stanley Foundation Brain Collection and Neuropathology Consortium. Schizophrenia Res 44, 151-155.
37. Kitada M, Rowitch DH (2006) Transcription factor co-expression patterns indicate heterogeneityofoligodendroglial subpopulations in adult spinal cord. Glia 54, 35-46.
38. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131, 1749-1758.
39. McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, Richtand NM (2007) Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 62, 17-24.
40. Nave KA, Trapp BD (2008) Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31, 535-561.
41. Van Hoesen GW, Parvizi J, Chu CC (2000) Orbitofrontal cortex pathology in Alzheimer's disease. Cereb Cortex 10, 243-251.
42. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, Kessaris N, Richardson WD (2008) PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 11, 1392-1401.
43. Zhu X, Bergles DE, Nishiyama A (2008) NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 135, 145-157.
44. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Kru-penko SA, Thompson WJ, Barres BA (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes:Anew resource for understanding brain development and function. J Neurosci 28, 264-278.
45. Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R (2006) Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9, 1520-1525.
46. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichie ME (1992) A functional anatomical study of unipolar depression. J Neurosci 12, 3628-3641.
47. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression: Treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61, 34-41.
48. Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M, Roiser JP, Neumeister A, Meyers N, Charney DS, Drevets WC (2008) Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 65, 521-531.
49. OngürD, Ferry AT, Price JL (2003) Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 460, 425-449.
50. Koechilin E, Hyafil A (2007) Anterior prefrontal function and the limits of human decision-making. Science 318, 594-598.
51. Yoshida W, Ishii S (2006) Resolution of uncertainty in pre-frontal cortex. Neuron 50, 781-789.
52. Ramnani N, Owen AM (2004) Anterior prefrontal cortex: Insights into function from anatomy and neuroimaging. Nat Rev Neurosci 5, 184-194.
53. Daw ND, O'Doherty JP, Dayan P, Seymour B, Dolan RJ (2006) Cortical substrates for exploratory decisions in humans. Nature 441, 876-879.